EMEA-002808-PIP01-20
Key facts
| Active substance |
Docosahexaenoic acid
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0058/2021
|
| PIP number |
EMEA-002808-PIP01-20
|
| Pharmaceutical form(s) |
Capsule, soft
|
| Condition(s) / indication(s) |
Treatment of Retinitis Pigmentosa
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Natac Pharma S.L.
E-mail: spomposiello@natac.es |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|